
    
      The BioMimics 3D stent is intended to improve luminal diameter in the treatment of
      symptomatic de-novo, obstructive or occlusive lesions in native femoropopliteal arteries with
      reference vessel diameters ranging from 4.0 - 6.0 mm. Subjects with symptomatic
      atherosclerotic disease of the femoropopliteal artery who comply with all study eligibility
      criteria may be considered for enrollment.
    
  